<?xml version="1.0" encoding="UTF-8" ?>

<rss version="2.0">
	<channel>
		<title>German Cancer Research Center</title>
		<link>http://www.dkfz.de</link>
		<description>Press releases of the German Cancer Research Center in Heidelberg</description>
		<docs>http://blogs.law.harvard.edu/tech/rss</docs> 
  	<generator>dkfz press feeds generator</generator>
  	<ttl>240</ttl>
  	
					<language>en-us</language>
				
   	  		<managingEditor>presse@dkfz.de</managingEditor>
				
					<webMaster>webmaster@dkfz.de</webMaster> 
				
					<copyright>Copyright by Deutsches Krebsforschungszentrum</copyright>
				
		
					<image>
				<title>German Cancer Research Center</title>
				<url>http://www.dkfz.de/xml/images/rss_logo_dkfz.jpg</url>
				<link>http://www.dkfz.de</link>
				
								<width>140</width>
										
								<height>41</height>
								
							</image>
				
		
				
					 
			<item>
  			<title><![CDATA[Defects in the packaging of genetic material in malignant brain tumors]]></title> 
  			<link>http://www.dkfz.de/en/presse/pressemitteilungen/2012/dkfz-pm-12-04-Defects-in-the-packaging-of-genetic-material-in-malignant-brain-tumors.php</link> 
  			<description><![CDATA[Glioblastomas are regarded as particularly aggressive brain tumors. In children with glioblastoma, Heidelberg scientists have now discovered genetic alterations that affect the function of DNA packaging proteins known as histones. In a cell, histones serve as coils around which the DNA wraps. At the same time, histones regulate gene activity. Mutations in histone genes have never before been tied to a disease. The group comprising scientists of the German Cancer Research Center, Heidelberg University Hospitals and McGill University in Canada have now reported their findings in Nature.]]></description> 
  			<pubDate>Mon, 30 Jan 2012 16:32:00 GMT</pubDate> 
  			<guid isPermaLink="true">http://www.dkfz.de/en/presse/pressemitteilungen/2012/dkfz-pm-12-04-Defects-in-the-packaging-of-genetic-material-in-malignant-brain-tumors.php</guid> 
  		</item>
  	
  				 
			<item>
  			<title><![CDATA[German Cancer Aid Award for Peter Krammer]]></title> 
  			<link>http://www.dkfz.de/en/presse/pressemitteilungen/2012/dkfz-pm-12-03-German-Cancer-Aid-Award-for-Peter-Krammer.php</link> 
  			<description><![CDATA[Professor Dr. Peter Krammer of the German Cancer Research (Deutsches Krebsforschungszentrum, DKFZ) is awarded the 2011 German Cancer Aid Award (Deutscher Krebshilfe-Preis 2011) jointly with Professor Dr. Klaus Michael Debatin of Ulm University Hospitals. The award is given to the two scientists in recognition of their pioneering research into signaling pathways which lead to cell death and can slow down cancer growth.]]></description> 
  			<pubDate>Thu, 26 Jan 2012 10:51:00 GMT</pubDate> 
  			<guid isPermaLink="true">http://www.dkfz.de/en/presse/pressemitteilungen/2012/dkfz-pm-12-03-German-Cancer-Aid-Award-for-Peter-Krammer.php</guid> 
  		</item>
  	
  				 
			<item>
  			<title><![CDATA[Self-regulation of the immune system suppresses defense against cancer]]></title> 
  			<link>http://www.dkfz.de/en/presse/pressemitteilungen/2011/dkfz-pm-11-69-Self-regulation-of-the-immune-system-suppresses-defense-against-cancer.php</link> 
  			<description><![CDATA[Regulatory T cells (Tregs), which are part of the body&#8217;s immune system, downregulate the activity of other immune cells, thus preventing the development of autoimmune diseases or allergies. Scientists at the German Cancer Research Center (DKFZ) have now found the activation steps that are blocked by Tregs in immune cells. Since Tregs can also suppress the body&#8217;s immune defense against cancer, the findings obtained by the DKFZ researchers are important for developing more efficient cancer treatments.]]></description> 
  			<pubDate>Wed, 21 Dec 2011 13:31:00 GMT</pubDate> 
  			<guid isPermaLink="true">http://www.dkfz.de/en/presse/pressemitteilungen/2011/dkfz-pm-11-69-Self-regulation-of-the-immune-system-suppresses-defense-against-cancer.php</guid> 
  		</item>
  	
  				 
			<item>
  			<title><![CDATA[No brakes on breast cancer cells]]></title> 
  			<link>http://www.dkfz.de/en/presse/pressemitteilungen/2011/dkfz-pm-11-68-No-brakes-on-breast-cancer-cells.php</link> 
  			<description><![CDATA[Scientists of the German Cancer Research Center (DKFZ) have discovered a tiny RNA molecule, called miR-520, which at once blocks two important pathways in the development of cancer in cells. In estrogen receptor-negative breast cancer, the production of this microRNA is often reduced and this is correlated with malignant behavior of tumor cells. The DKFZ team has found out that tumors with low levels of miR-520 have a particularly strong tendency to metastasize.]]></description> 
  			<pubDate>Thu, 15 Dec 2011 17:11:00 GMT</pubDate> 
  			<guid isPermaLink="true">http://www.dkfz.de/en/presse/pressemitteilungen/2011/dkfz-pm-11-68-No-brakes-on-breast-cancer-cells.php</guid> 
  		</item>
  	
  				 
			<item>
  			<title><![CDATA[Two ERC grants go to the German Cancer Research Center]]></title> 
  			<link>http://www.dkfz.de/en/presse/pressemitteilungen/2011/dkfz-pm-11-66-Two-ERC-grants-go-to-the-German-Cancer-Research-Center.php</link> 
  			<description><![CDATA[Two DKFZ researchers at a time are awarded a prestigious European Research Council (ERC) Advanced Grant this year. One of the grants is awarded to a project of Prof. Michael Boutros, who endeavors to show, for the first time, the interaction of all genes in cells of a higher organism. Prof. Bruno Kyewski is awarded an ERC grant for his studies of how immune cells learn tolerance of the body&#8217;s own structures.]]></description> 
  			<pubDate>Tue, 06 Dec 2011 12:44:00 GMT</pubDate> 
  			<guid isPermaLink="true">http://www.dkfz.de/en/presse/pressemitteilungen/2011/dkfz-pm-11-66-Two-ERC-grants-go-to-the-German-Cancer-Research-Center.php</guid> 
  		</item>
  	
  				 
			<item>
  			<title><![CDATA[Oxidative stress: Less harmful than suspected?]]></title> 
  			<link>http://www.dkfz.de/en/presse/pressemitteilungen/2011/dkfz-pm-11-65-Oxidative-stress-Less-harmful-than-suspected.php</link> 
  			<description><![CDATA[Oxidative stress is considered to be involved in a multitude of pathogenic processes and is also implicated in the proces of aging. For the first time, scientists of the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) have been able to directly observe oxidative changes in a living organism. Their findings in fruit flies raise doubts about the validity of some widely held hypotheses: The research team has found no evidence that the life span is limited by the production of harmful oxidants.]]></description> 
  			<pubDate>Mon, 05 Dec 2011 14:03:00 GMT</pubDate> 
  			<guid isPermaLink="true">http://www.dkfz.de/en/presse/pressemitteilungen/2011/dkfz-pm-11-65-Oxidative-stress-Less-harmful-than-suspected.php</guid> 
  		</item>
  	
  				 
			<item>
  			<title><![CDATA[Mysterious cells of the immune system: Immunologists at the German Cancer Research Center question the role of mast cells in autoimmune diseases]]></title> 
  			<link>http://www.dkfz.de/en/presse/pressemitteilungen/2011/dkfz-pm-11-64-Mysterious-cells-of-the-immune-system.php</link> 
  			<description><![CDATA[Up to now, scientists have assumed that mast cells, a certain type of immune cells, play a central role in the development of autoimmune diseases such as rheumatoid arthritis and multiple sclerosis. Current studies conducted at the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) have now provided evidence to refute this assumption. Now it is only the mast cells&#8217; central function in allergies that remains undisputed.]]></description> 
  			<pubDate>Tue, 29 Nov 2011 14:53:00 GMT</pubDate> 
  			<guid isPermaLink="true">http://www.dkfz.de/en/presse/pressemitteilungen/2011/dkfz-pm-11-64-Mysterious-cells-of-the-immune-system.php</guid> 
  		</item>
  	
  				 
			<item>
  			<title><![CDATA[Fighting Fat With Fat]]></title> 
  			<link>http://www.dkfz.de/en/presse/pressemitteilungen/2011/dkfz-pm-11-63-Fighting-Fat-With-Fat.php</link> 
  			<description><![CDATA[Coordinated by the German Cancer Research Center (DKFZ), a European research consortium is searching for ways to use brown fat tissue for combating widespread diseases such as type 2 diabetes and metabolic syndrome.]]></description> 
  			<pubDate>Thu, 24 Nov 2011 11:53:00 GMT</pubDate> 
  			<guid isPermaLink="true">http://www.dkfz.de/en/presse/pressemitteilungen/2011/dkfz-pm-11-63-Fighting-Fat-With-Fat.php</guid> 
  		</item>
  	
  				 
			<item>
  			<title><![CDATA[Enhanced treatment of brain tumors]]></title> 
  			<link>http://www.dkfz.de/en/presse/pressemitteilungen/2011/dkfz-pm-11-62-Enhanced-treatment-of-brain-tumors.php</link> 
  			<description><![CDATA[Scientists of the German Cancer Research Center (DKFZ) and Heidelberg University Hospitals have tested a combination of radiation treatment and a substance that blocks the transforming growth factor beta (TGF- &#946;) for treating glioblastoma. In the mouse model, this combination therapy was found to be more effective in slowing down the growth of such malignant brain tumors and to prolong survival of the animals. Researchers will now conduct a multicenter clinical trial to find out whether patients might also benefit from a combination of radiotherapy, chemotherapy and growth factor blocking.]]></description> 
  			<pubDate>Wed, 23 Nov 2011 11:10:00 GMT</pubDate> 
  			<guid isPermaLink="true">http://www.dkfz.de/en/presse/pressemitteilungen/2011/dkfz-pm-11-62-Enhanced-treatment-of-brain-tumors.php</guid> 
  		</item>
  	
  				 
			<item>
  			<title><![CDATA[From microscopy to nanoscopy: 2011 Meyenburg Award goes to Stefan Hell]]></title> 
  			<link>http://www.dkfz.de/en/presse/pressemitteilungen/2011/dkfz-11-61-Meyenburg-Award-goes-to-Stefan-Hell.php</link> 
  			<description><![CDATA[The EUR 50,000 Meyenburg Award in 2011 goes to physicist Stefan Hell. He is honored for developing a whole new kind of light microscopy which makes it possible for the first time to observe living cells down to nanomolecular scale. The Meyenburg Award will be presented on Thursday, November 17, 2011 at a symposium held at the German Cancer Research Center (DKFZ).]]></description> 
  			<pubDate>Wed, 16 Nov 2011 16:34:00 GMT</pubDate> 
  			<guid isPermaLink="true">http://www.dkfz.de/en/presse/pressemitteilungen/2011/dkfz-11-61-Meyenburg-Award-goes-to-Stefan-Hell.php</guid> 
  		</item>
  	
  				 
			<item>
  			<title><![CDATA[Using Viagra to Combat Malignant Melanoma]]></title> 
  			<link>http://www.dkfz.de/en/presse/pressemitteilungen/2011/dkfz-pm-11-60-Using-Viagra-to-Combat-Malignant-Melanoma.php</link> 
  			<description><![CDATA[Many tumors cause chronic inflammations, which, in their turn, suppress specific attacks against the tumor by the immune system. Scientists at the German Cancer Research Center (DKFZ) and Medical Faculty Mannheim at Heidelberg University have now shown in mice with melanoma that sildenafil &#8211; the active ingredient in Viagra® &#8211; cancels the suppression of the specific immune response. Cancerous mice treated with the drug survived more than twice as long as untreated fellow animals.]]></description> 
  			<pubDate>Tue, 08 Nov 2011 14:30:00 GMT</pubDate> 
  			<guid isPermaLink="true">http://www.dkfz.de/en/presse/pressemitteilungen/2011/dkfz-pm-11-60-Using-Viagra-to-Combat-Malignant-Melanoma.php</guid> 
  		</item>
  	
  				 
			<item>
  			<title><![CDATA[Comprehensible, personal, up-to-date and rapid: E-mail service of the Cancer Information Service gets good grades from users in a survey]]></title> 
  			<link>http://www.dkfz.de/en/presse/pressemitteilungen/2011/dkfz-pm-11-59-E-mail-service-of-the-Cancer-Information-Service-gets-good-grades-from-users-in-a-survey.php</link> 
  			<description><![CDATA[Have we been able to help you with your inquiry at the Cancer Information Service? The e-mail service of the Cancer Information Service (Krebsinformationsdienst, KID) has questioned its users about this. The survey produced a positive result: Almost all of those questioned found the responses provided by the Cancer Information Service easy to understand and helpful in their situation. Ninety-six percent are very satisfied or satisfied with the performance of the e-mail service. Participants in the survey particularly appreciated that the Cancer Information Service provides personal responses to every inquiry.]]></description> 
  			<pubDate>Mon, 07 Nov 2011 14:48:00 GMT</pubDate> 
  			<guid isPermaLink="true">http://www.dkfz.de/en/presse/pressemitteilungen/2011/dkfz-pm-11-59-E-mail-service-of-the-Cancer-Information-Service-gets-good-grades-from-users-in-a-survey.php</guid> 
  		</item>
  	
  				 
			<item>
  			<title><![CDATA[Alternate ending  living on without telomerase]]></title> 
  			<link>http://www.dkfz.de/en/presse/pressemitteilungen/2011/dkfz-pm-11-58-Alternate-ending-living-on-without-telomerase.php</link> 
  			<description><![CDATA[Scientists of the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) have discovered an alternative mechanism for the extension of the telomere repeat sequence by DNA repair enzymes.]]></description> 
  			<pubDate>Thu, 03 Nov 2011 10:52:00 GMT</pubDate> 
  			<guid isPermaLink="true">http://www.dkfz.de/en/presse/pressemitteilungen/2011/dkfz-pm-11-58-Alternate-ending-living-on-without-telomerase.php</guid> 
  		</item>
  	
  				 
			<item>
  			<title><![CDATA[Growth Without Cell Division: Heidelberg Researchers Describe Alternative Cell Cycle]]></title> 
  			<link>http://www.dkfz.de/en/presse/pressemitteilungen/2011/dkfz-pm-11-57-Growth-Without-Cell-Division-Heidelberg-Researchers-Describe-Alternative-Cell-Cycle.php</link> 
  			<description><![CDATA[When animals or humans grow, this is normally accomplished by many successive cell divisions. In plants and also in many simple animals, there is an alternative growth strategy: Cells double their genetic material and their other components and, thus, also their size without subsequently dividing into two daughter cells. Several such &#8220;endocycles&#8221; generate giant cells which can grow up to one thousand times the size of a normal cell. Scientists of the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) and Heidelberg University have now found out how endocycles are controlled. Today they have reported their results in Nature.
Joint Press Release by Heidelberg University and German Cancer Research Center in the Helmholtz Association]]></description> 
  			<pubDate>Mon, 31 Oct 2011 15:56:00 GMT</pubDate> 
  			<guid isPermaLink="true">http://www.dkfz.de/en/presse/pressemitteilungen/2011/dkfz-pm-11-57-Growth-Without-Cell-Division-Heidelberg-Researchers-Describe-Alternative-Cell-Cycle.php</guid> 
  		</item>
  	
  				 
			<item>
  			<title><![CDATA[Using Viruses to Fight Brain Tumors]]></title> 
  			<link>http://www.dkfz.de/en/presse/pressemitteilungen/2011/dkfz-pm-11-56-Using-Viruses-to-Fight-Brain-Tumors.php</link> 
  			<description><![CDATA[Bridging the Gap Between Research and Clinical Application
Parvoviruses can enter and kill cancer cells, but they do not cause disease in humans. Since 1992, scientists at the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) have been studying these viruses with the aim of developing a viral therapy against dangerous brain tumors that are almost impossible to treat. This week, the first ever phase I/IIa clinical trial will start at the Neurosurgery Department of Heidelberg University Hospital to test the safety of parvovirus therapy. Developing this innovative treatment method to the stage of clinical application has been made possible in collaboration with Oryx GmbH &amp; Co KG.]]></description> 
  			<pubDate>Fri, 28 Oct 2011 15:47:00 GMT</pubDate> 
  			<guid isPermaLink="true">http://www.dkfz.de/en/presse/pressemitteilungen/2011/dkfz-pm-11-56-Using-Viruses-to-Fight-Brain-Tumors.php</guid> 
  		</item>
  	
  				 
			<item>
  			<title><![CDATA[Cigarette Advertising in Germany and Japan: Cancer Research Centers of Both Countries Present Alarming Report]]></title> 
  			<link>http://www.dkfz.de/en/presse/pressemitteilungen/2011/dkfz-pm-11-55-Cigarette-Advertising-in-Germany-and-Japan-Cancer-Research-Centers-of-Both-Countries-Present-Alarming-Report.php</link> 
  			<description><![CDATA[People in Germany and Japan are exposed to massive cigarette advertising every day &#8211; while shopping in supermarkets, shops and stores, at gas stations, on about 400,000 cigarette vending machines in both countries, in public transport waiting areas, in bars and restaurants and at leisure events. This is the result of a documentation on tobacco advertising presented by the German Cancer Research Center (DKFZ) and the National Cancer Center in Japan on the occasion of the World Health Summit 2011 in Berlin.]]></description> 
  			<pubDate>Wed, 26 Oct 2011 13:46:00 GMT</pubDate> 
  			<guid isPermaLink="true">http://www.dkfz.de/en/presse/pressemitteilungen/2011/dkfz-pm-11-55-Cigarette-Advertising-in-Germany-and-Japan-Cancer-Research-Centers-of-Both-Countries-Present-Alarming-Report.php</guid> 
  		</item>
  	
  				 
			<item>
  			<title><![CDATA[Molecular Biologist Bruce Edgar and Stem Cell Researcher Andreas Trumpp Acknowledged for Achievements in Life Sciences]]></title> 
  			<link>http://www.dkfz.de/en/presse/pressemitteilungen/2011/dkfz-pm-11-54a-eMolecular-Biologist-Bruce-Edgar-and-Stem-Cell-Researcher-Andreas-Trumpp-Acknowledged-for-Achievements-in-Life-Sciences.php</link> 
  			<description><![CDATA[Heidelberg researchers elected to become members of the European Molecular Biology Organization (EMBO)]]></description> 
  			<pubDate>Tue, 25 Oct 2011 10:52:00 GMT</pubDate> 
  			<guid isPermaLink="true">http://www.dkfz.de/en/presse/pressemitteilungen/2011/dkfz-pm-11-54a-eMolecular-Biologist-Bruce-Edgar-and-Stem-Cell-Researcher-Andreas-Trumpp-Acknowledged-for-Achievements-in-Life-Sciences.php</guid> 
  		</item>
  	
  				 
			<item>
  			<title><![CDATA[Autoimmune Diseases Affect Cancer Risk]]></title> 
  			<link>http://www.dkfz.de/en/presse/pressemitteilungen/2011/dkfz-pm-11-54-Autoimmune-Diseases-Affect-Cancer-Risk.php</link> 
  			<description><![CDATA[In a recently published study, scientists of the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) have calculated the interrelations between autoimmune diseases and cancer of the digestive tract. They discovered that many autoimmune diseases increase the cancer risk, while others, such as rheumatism, are associated with a significantly lower bowel cancer risk. These differing impacts on cancer risk may be attributable to the medications administered.]]></description> 
  			<pubDate>Mon, 10 Oct 2011 11:05:00 GMT</pubDate> 
  			<guid isPermaLink="true">http://www.dkfz.de/en/presse/pressemitteilungen/2011/dkfz-pm-11-54-Autoimmune-Diseases-Affect-Cancer-Risk.php</guid> 
  		</item>
  	
  				 
			<item>
  			<title><![CDATA[Dioxin-like Chemical Messenger Makes Brain Tumors More Aggressive]]></title> 
  			<link>http://www.dkfz.de/en/presse/pressemitteilungen/2011/dkfz-pm-11-53a-Dioxin-like-Chemical-Messenger-Makes-Brain-Tumors-More-Aggressive.php</link> 
  			<description><![CDATA[Scientists of the German Cancer Research Center (DKFZ) and Heidelberg University Hospital have discovered a new metabolic pathway / Successful research alliance publishes results in Nature
Joint Press Release of the German Cancer Research Center and Heidelberg University Hospitals]]></description> 
  			<pubDate>Thu, 06 Oct 2011 16:01:00 GMT</pubDate> 
  			<guid isPermaLink="true">http://www.dkfz.de/en/presse/pressemitteilungen/2011/dkfz-pm-11-53a-Dioxin-like-Chemical-Messenger-Makes-Brain-Tumors-More-Aggressive.php</guid> 
  		</item>
  	
  				 
			<item>
  			<title><![CDATA[Support for New Helmholtz Junior Research Group: Start-Up Funding for Young Cancer Researcher]]></title> 
  			<link>http://www.dkfz.de/en/presse/pressemitteilungen/2011/dkfz-pm-11-53-Support-for-New-Helmholtz-Junior-Research-Group.php</link> 
  			<description><![CDATA[A new Helmholtz Junior Research Group will be established at the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ). The Helmholtz-Association has chosen Dr. Andreas Fischer, jointly with 19 other outstanding young scientists, out of 220 high-profile applicants from Germany and abroad.]]></description> 
  			<pubDate>Mon, 26 Sep 2011 11:45:00 GMT</pubDate> 
  			<guid isPermaLink="true">http://www.dkfz.de/en/presse/pressemitteilungen/2011/dkfz-pm-11-53-Support-for-New-Helmholtz-Junior-Research-Group.php</guid> 
  		</item>
  	
  	  
	</channel>
</rss>

